Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Escott-Price V., Bellenguez C., Wang L-S., Choi S-H., Harold D., Jones L., Holmans P., Gerrish A., Vedernikov A., Richards A., DeStefano AL., Lambert J-C., Ibrahim-Verbaas CA., Naj AC., Sims R., Jun G., Bis JC., Beecham GW., Grenier-Boley B., Russo G., Thornton-Wells TA., Denning N., Smith AV., Chouraki V., Thomas C., Ikram MA., Zelenika D., Vardarajan BN., Kamatani Y., Lin C-F., Schmidt H., Kunkle B., Dunstan ML., Vronskaya M., United Kingdom Brain Expression Consortium None., Johnson AD., Ruiz A., Bihoreau M-T., Reitz C., Pasquier F., Hollingworth P., Hanon O., Fitzpatrick AL., Buxbaum JD., Campion D., Crane PK., Baldwin C., Becker T., Gudnason V., Cruchaga C., Craig D., Amin N., Berr C., Lopez OL., De Jager PL., Deramecourt V., Johnston JA., Evans D., Lovestone S., Letenneur L., Hernández I., Rubinsztein DC., Eiriksdottir G., Sleegers K., Goate AM., Fiévet N., Huentelman MJ., Gill M., Brown K., Kamboh MI., Keller L., Barberger-Gateau P., McGuinness B., Larson EB., Myers AJ., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., George-Hyslop PS., Clarimon J., Lleo A., Bayer A., Tsuang DW., Yu L., Tsolaki M., Bossù P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Garcia FS., Fox NC., Hardy J., Naranjo MCD., Bosco P., Clarke R., Brayne C., Galimberti D., Scarpini E., Bonuccelli U., Mancuso M., Siciliano G., Moebus S., Mecocci P., Zompo MD., Maier W., Hampel H., Pilotto A., Frank-García A., Panza F., Solfrizzi V., Caffarra P., Nacmias B., Perry W., Mayhaus M., Lannfelt L., Hakonarson H., Pichler S., Carrasquillo MM., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin SG., Coto E., Hamilton-Nelson KL., Gu W., Razquin C., Pastor P., Mateo I., Owen MJ., Faber KM., Jonsson PV., Combarros O., O'Donovan MC., Cantwell LB., Soininen H., Blacker D., Mead S., Mosley TH., Bennett DA., Harris TB., Fratiglioni L., Holmes C., de Bruijn RFAG., Passmore P., Montine TJ., Bettens K., Rotter JI., Brice A., Morgan K., Foroud TM., Kukull WA., Hannequin D., Powell JF., Nalls MA., Ritchie K., Lunetta KL., Kauwe JSK., Boerwinkle E., Riemenschneider M., Boada M., Hiltunen M., Martin ER., Schmidt R., Rujescu D., Dartigues J-F., Mayeux R., Tzourio C., Hofman A., Nöthen MM., Graff C., Psaty BM., Haines JL., Lathrop M., Pericak-Vance MA., Launer LJ., Van Broeckhoven C., Farrer LA., van Duijn CM., Ramirez A., Seshadri S., Schellenberg GD., Amouyel P., Williams J., Cardiovascular Health Study (CHS) None.
BACKGROUND: Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought to identify new susceptibility genes, using an alternative gene-wide analytical approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 m genotypes from 25,580 Alzheimer's cases and 48,466 controls. PRINCIPAL FINDINGS: In addition to earlier reported genes, we detected genome-wide significant loci on chromosomes 8 (TP53INP1, p = 1.4×10-6) and 14 (IGHV1-67 p = 7.9×10-8) which indexed novel susceptibility loci. SIGNIFICANCE: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimer's disease.